Go with your gut: Research sheds light on how microbes can interact with drugs

February 15, 2013 by Peter Reuell, Harvard University
In a recent paper in Cell, Peter Turnbaugh (pictured) and fellow researchers show that as drugs are administered, the activity of human gut microbes can change dramatically. Credit: Kris Snibbe/Harvard Staff Photographer

Scientists are already working to develop treatments that can be tailored to an individual's genetics, but what about tailoring treatments based on the genetics of the trillions of microbes that live in a person's gut?

The idea might not be as far-fetched as it sounds, said Peter Turnbaugh, a Bauer Fellow at Harvard's Faculty of Arts and Sciences (FAS) Center for Systems Biology.

In a recent paper in Cell, Turnbaugh and co-authors Corinne Ferrier Maurice and Henry Joseph Haiser, both postdoctoral fellows at the Center for , show that, as drugs are administered, the activity of human can change dramatically. Understanding how those changes affect drugs could one day help researchers to design drugs that work more effectively and antibiotics that more specifically target pathogens.

"The big question is: To what extent do the benefits and side effects of different types of drugs depend on the microbes in our gut?" Turnbaugh said. "For decades, we have known they can play some role. The microbes inhabiting our gut are able to change the structure of drugs in ways that can contribute to toxicity, or to activate or inactivate compounds. In almost all cases, however, we don't know the particular microbes that are responsible, the genes they may be using, or the factors that promote or inhibit these activities."

Previously, Maurice and Haiser could examine how the microbes in the gut reacted to various treatments. However, they wanted to know exactly which microbes were there, and whether all were equally active.

To get at that question, they turned to a technique borrowed from aquatic .

They first marked cells with a series of three stains designed to highlight whether and how severely cells were damaged, and how active the cells were, based on the amount of DNA and RNA they contained. Using a flow cytometer, a device that uses lasers to count and sort cells precisely, they were able to determine how many of each type of cell were present in the samples.

"Our initial view suggests that the gut microbiota is quite active relative to other environments, and there's also a substantial percentage—around 30 percent—of damaged cells," Turnbaugh said. "We also found that both the active and damaged groups were primarily made up of Firmicutes, one of the two major groups of bacteria in the gut. That suggests that the Firmicutes may be more highly active than other members of our gut microbial community."

Armed with that data, researchers used next-generation sequencing to study how the gene expression of the bacteria changed as six drugs and eight antibiotics were administered.

"We know that at least some members of the community are able to change these drugs. Our hope was that finding changes in gene expression would give us a clue as to who is responsible and what they might be using," Turnbaugh said. "We were able to identify a variety of changes in , many of them consistent with the known biochemical changes to each compound, providing a starting point for more mechanistic studies."

For the various antibiotics they tested, Turnbaugh said, colleagues were surprised to see different responses between individuals and for each individual on different days.

"The main goal of is to eliminate pathogenic bacteria, but we're learning that there are many side effects that these drugs have on the microbes that are normally found in the gut, which may have negative consequences," he said. "There has been a great deal of emphasis on personalized medicine in recent years, and the standard way of thinking about that is understanding the human genome and trying to predict how a given will react inside your body. I think this paper emphasizes that it may be equally important to think about how your particular gut microbiota will interact with a given drug."

Explore further: Breastfeeding is associated with a healthy infant gut

Related Stories

Breastfeeding is associated with a healthy infant gut

April 30, 2012
Early colonization of the gut by microbes in infants is critical for development of their intestinal tract and in immune development. A new study, published in BioMed Central's open access journal Genome Biology, shows that ...

Could 'friendly' gut bacteria help fight heart disease?

July 17, 2012
(Medical Xpress) -- Scientists at the University of Reading are looking at ways of tackling heart disease and diabetes - through our guts.

'Unhealthy' changes in gut microbes benefit pregnant women

August 2, 2012
The composition of microbes in the gut changes dramatically during pregnancy, according to a study published by Cell Press in the August 3rd issue of the journal Cell. Although these changes are associated with metabolic ...

Recommended for you

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.